Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

Wow, I used to respect the Motley fool's writers. they were thorough, well thought out, and, usually both complete and accurate.

This writer has done little research, if any. He hasn't even looked at ACAD's pipeline let alone the last couple PRs.

Approval for both MDD and ADP appear imminent, each of which are likely to be blockbusters.

On the horizon is a tx for female sexual dysfunction, another first of its kind.

I'd be surprised if a much better entry point presents itself any time soon.